-
公开(公告)号：US08889673B2
公开(公告)日：2014-11-18
申请号：US13529946
申请日：2012-06-21
Applicant: Bing-Yan Zhu , Michael Siu , Steven R. Magnuson , Richard Pastor , He Haiying , Xiao Yisong , Zheng Jifu , Xu Xing , Zhao Junping , Wendy Liu
Inventor： Bing-Yan Zhu , Michael Siu , Steven R. Magnuson , Richard Pastor , He Haiying , Xiao Yisong , Zheng Jifu , Xu Xing , Zhao Junping , Wendy Liu
IPC: A61K31/5377 , A61K31/454 , A61K31/497 , A61K31/4196 , A61K31/4439 , A61K31/496 , C07D211/00 , C07D413/02 , C07D403/02 , C07D249/08 , C07D401/02 , C07D471/04
CPC classification number: C07D471/04 , A61K31/437 , A61K31/444 , A61K31/4545 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/541 , A61K45/06
Abstract: A compound of Formula I, enantiomers, diasteriomers, tautomers or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined herein, are useful as JAK kinase inhibitors. A pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of JAK kinase activity in a patient are disclosed.
Abstract translation: 其中R 1，R 2，R 3，R 4和R 5在本文中定义的式I化合物，对映异构体，非对映异构体，互变异构体或其药学上可接受的盐可用作JAK激酶抑制剂。 公开了包含式I化合物和药学上可接受的载体，佐剂或载体的药物组合物，以及治疗或减轻对患者中JAK激酶活性的抑制作用的疾病或病症的严重程度的方法。
-
公开(公告)号：US08390627B2
公开(公告)日：2013-03-05
申请号：US12567809
申请日：2009-09-28
Applicant: Xu-Xing Yan
Inventor： Xu-Xing Yan
CPC classification number: G06F3/0233 , H04M1/72594
Abstract: A text processing device and text processing method are provided. The method includes steps: receiving input characters; displaying current input characters with a predetermined magnification ratio; judging whether length of the input characters is more than the predetermined maximum length, if not, receiving input characters, and if yes, adjusting display state on the text processing device according to the predetermined magnification ratio and the predetermined maximum length.
Abstract translation: 提供文本处理装置和文本处理方法。 该方法包括步骤：接收输入字符; 以预定的放大率显示当前输入字符; 判断输入字符的长度是否大于预定的最大长度，否则接收输入字符，如果是，则根据预定的倍率和预定的最大长度来调整文本处理装置上的显示状态。
-
公开(公告)号：US20120264747A1
公开(公告)日：2012-10-18
申请号：US13529946
申请日：2012-06-21
Applicant: Bing-Yan Zhu , Michael Siu , Steven R. Magnuson , Richard Pastor , He Haiying , Xiao Yisong , Zheng Jifu , Xu Xing , Zhao Junping , Wendy Liu
Inventor： Bing-Yan Zhu , Michael Siu , Steven R. Magnuson , Richard Pastor , He Haiying , Xiao Yisong , Zheng Jifu , Xu Xing , Zhao Junping , Wendy Liu
IPC: A61K31/437 , A61K31/496 , A61K31/5377 , A61K31/506 , A61K31/541 , A61P17/06 , A61P3/10 , A61P9/00 , A61P25/00 , A61P25/28 , A61P31/12 , A61P9/10 , C07D471/04 , A61P35/00
CPC classification number: C07D471/04 , A61K31/437 , A61K31/444 , A61K31/4545 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/541 , A61K45/06
Abstract: A compound of Formula I, enantiomers, diasteriomers, tautomers or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined herein, are useful as JAK kinase inhibitors. A pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of JAK kinase activity in a patient are disclosed.
Abstract translation: 其中R 1，R 2，R 3，R 4和R 5在本文中定义的式I化合物，对映异构体，非对映异构体，互变异构体或其药学上可接受的盐可用作JAK激酶抑制剂。 公开了包含式I化合物和药学上可接受的载体，佐剂或载体的药物组合物，以及治疗或减轻对患者中JAK激酶活性的抑制作用的疾病或病症的严重程度的方法。
-
公开(公告)号：US20110055608A1
公开(公告)日：2011-03-03
申请号：US12564930
申请日：2009-09-23
Applicant: LEI JIN , XU-XING YAN
Inventor： LEI JIN , XU-XING YAN
IPC: G06F1/26
CPC classification number: G06F1/3203 , G06F1/1616 , G06F1/1677
Abstract: An exemplary embodiment of notebook computer includes a main body, a display, and a proximity sensor. The display is pivotably connected to the main body. The proximity sensor is installed in the main body and includes an emitter and a receiver. The emitter is configured for emitting an emission. The receiver is configure for receiving the emission, determining if an included angle between the main body and the display is in a predetermined range based upon the received emission, and, if yes, generating a signal indicative of placing the notebook computer in the sleep mode.
Abstract translation: 笔记本电脑的示例性实施例包括主体，显示器和接近传感器。 显示器可枢转地连接到主体。 接近传感器安装在主体中并包括发射器和接收器。 发射极被配置为发射发射。 接收器被配置为接收发射，基于接收到的发射来确定主体和显示器之间的夹角是否在预定范围内，并且如果是，则产生指示将笔记本计算机置于睡眠模式的信号 。
-
公开(公告)号：US20110055157A1
公开(公告)日：2011-03-03
申请号：US12606193
申请日：2009-10-27
Applicant: XU-XING YAN
Inventor： XU-XING YAN
CPC classification number: G06F16/16
Abstract: An electronic apparatus with an automatic file copying function is provided. The electronic apparatus comprises a processing unit and a data storage. When detecting a mobile data storage is connected to the electronic apparatus, the processing unit detects whether there are files with a predetermined marking in the mobile data storage, and copies the files with the predetermined marking in the mobile data storage to the data storage if there are files with the predetermined marking in the mobile data storage.
Abstract translation: 提供具有自动文件复制功能的电子设备。 电子设备包括处理单元和数据存储器。 当检测到移动数据存储器连接到电子设备时，处理单元检测在移动数据存储器中是否存在具有预定标记的文件，并且在移动数据存储器中将具有预定标记的文件复制到数据存储器，如果有 是在移动数据存储器中具有预定标记的文件。
-
Patent Agency Ranking
公开(公告)号：US20100309229A1
公开(公告)日：2010-12-09
申请号：US12567809
申请日：2009-09-28
Applicant: XU-XING YAN
Inventor： XU-XING YAN
IPC: G09G5/00
CPC classification number: G06F3/0233 , H04M1/72594
Abstract: A text processing device and text processing method are provided. The method includes steps: receiving input characters; displaying current input characters with a predetermined magnification ratio; judging whether length of the input characters is more than the predetermined maximum length, if not, receiving input characters, and if yes, adjusting display state on the text processing device according to the predetermined magnification ratio and the predetermined maximum length.
Abstract translation: 提供文本处理装置和文本处理方法。 该方法包括步骤：接收输入字符; 以预定的放大率显示当前输入字符; 判断输入字符的长度是否大于预定的最大长度，否则接收输入字符，如果是，则根据预定的倍率和预定的最大长度来调整文本处理装置上的显示状态。
-
公开(公告)号：US20100048557A1
公开(公告)日：2010-02-25
申请号：US12488312
申请日：2009-06-19
Applicant: Bing-Yan ZHU , Michael SIU , Steven R. MAGNUSON , Richard PASTOR , He HAIYING , Xiao YISONG , Zheng JIFU , Xu XING , Zhao JUNPING
Inventor： Bing-Yan ZHU , Michael SIU , Steven R. MAGNUSON , Richard PASTOR , He HAIYING , Xiao YISONG , Zheng JIFU , Xu XING , Zhao JUNPING
IPC: A61K31/437 , C07D471/04 , A61K31/496 , A61K31/5377 , A61P35/00 , A61P3/10 , A61P9/00 , A61P31/12 , A61P37/00 , A61P29/00 , A61P25/00
CPC classification number: C07D471/04 , A61K31/437 , A61K31/496 , A61K31/5377 , C07D487/04
Abstract: A compound of Formula I, enantiomers, diasteriomers, tautomers or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined herein, are useful as JAK kinase inhibitors. A pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of JAK kinase activity in a patient are disclosed.
Abstract translation: 其中R 1，R 2，R 3，R 4和R 5在本文中定义的式I化合物，对映异构体，非对映异构体，互变异构体或其药学上可接受的盐可用作JAK激酶抑制剂。 公开了包含式I化合物和药学上可接受的载体，佐剂或载体的药物组合物，以及治疗或减轻对患者中JAK激酶活性的抑制作用的疾病或病症的严重程度的方法。
-
公开(公告)号：US20100035875A1
公开(公告)日：2010-02-11
申请号：US12488406
申请日：2009-06-19
Applicant: Bing-Yan ZHU , Michael SIU , Steven R. MAGNUSON , Richard PASTOR , He HAIYING , Xiao YISONG , Zheng JIFU , Xu XING , Zhao JUNPING , Wendy LIU
Inventor： Bing-Yan ZHU , Michael SIU , Steven R. MAGNUSON , Richard PASTOR , He HAIYING , Xiao YISONG , Zheng JIFU , Xu XING , Zhao JUNPING , Wendy LIU
IPC: A61K31/437 , C07D471/04 , A61K31/496 , A61K31/5377 , A61P35/00 , A61P9/00 , A61P37/00 , A61P29/00 , A61P19/00 , A61P25/00
CPC classification number: C07D471/04 , A61K31/437 , A61K31/444 , A61K31/4545 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/541 , A61K45/06
Abstract: A compound of Formula I, enantiomers, diasteriomers, tautomers or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined herein, are useful as JAK kinase inhibitors. A pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of JAK kinase activity in a patient are disclosed.
Abstract translation: 其中R 1，R 2，R 3，R 4和R 5在本文中定义的式I化合物，对映异构体，非对映异构体，互变异构体或其药学上可接受的盐可用作JAK激酶抑制剂。 公开了包含式I化合物和药学上可接受的载体，佐剂或载体的药物组合物，以及治疗或减轻对患者中JAK激酶活性的抑制作用的疾病或病症的严重程度的方法。
-
公开(公告)号：US08609687B2
公开(公告)日：2013-12-17
申请号：US13471269
申请日：2012-05-14
Applicant: Bing-Yan Zhu , Michael Siu , Steven R. Magnuson , Richard Pastor , He Haiying , Xiao Yisong , Zheng Jifu , Xu Xing , Zhao Junping , Christopher Hurley , Jun Liang , Wendy Liu , Joseph P. Lyssikatos
Inventor： Bing-Yan Zhu , Michael Siu , Steven R. Magnuson , Richard Pastor , He Haiying , Xiao Yisong , Zheng Jifu , Xu Xing , Zhao Junping , Christopher Hurley , Jun Liang , Wendy Liu , Joseph P. Lyssikatos
IPC: A61K31/437 , C07D471/02
CPC classification number: C07D471/04 , A61K31/437 , A61K31/496 , A61K31/5377 , C07D487/04
Abstract: A compound of Formula I, enantiomers, diasteriomers, tautomers or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined herein, are useful as JAK kinase inhibitors. A pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of JAK kinase activity in a patient are disclosed.
Abstract translation: 其中R 1，R 2，R 3，R 4和R 5在本文中定义的式I化合物，对映异构体，非对映异构体，互变异构体或其药学上可接受的盐可用作JAK激酶抑制剂。 公开了包含式I化合物和药学上可接受的载体，佐剂或载体的药物组合物，以及治疗或减轻对患者中JAK激酶活性的抑制作用的疾病或病症的严重程度的方法。
-
公开(公告)号：US08321709B2
公开(公告)日：2012-11-27
申请号：US12564930
申请日：2009-09-23
Applicant: Lei Jin , Xu-Xing Yan
Inventor： Lei Jin , Xu-Xing Yan
CPC classification number: G06F1/3203 , G06F1/1616 , G06F1/1677
Abstract: An exemplary embodiment of notebook computer includes a main body, a display, and a proximity sensor. The display is pivotably connected to the main body. The proximity sensor is installed in the main body and includes an emitter and a receiver. The emitter is configured for emitting an emission. The receiver is configure for receiving the emission, determining if an included angle between the main body and the display is in a predetermined range based upon the received emission, and, if yes, generating a signal indicative of placing the notebook computer in the sleep mode.
Abstract translation: 笔记本电脑的示例性实施例包括主体，显示器和接近传感器。 显示器可枢转地连接到主体。 接近传感器安装在主体中并包括发射器和接收器。 发射极被配置为发射发射。 接收器被配置为接收发射，基于接收到的发射来确定主体和显示器之间的夹角是否在预定范围内，并且如果是，则产生指示将笔记本计算机置于睡眠模式的信号 。
-
-
-
-
-
-
-
-
-
Search Results
12
records
(took 0.023 seconds)
